Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus

4-hydroxycoumarin-3-carboxamides for the treatment of diabetes mellitus

US Patent 5723476 · Granted Mar 3, 1998

Estimated economic value: $150,738,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compositions and methods for reducing immune intolerance and treating autoimmune2025
Compositions and methods for reducing immune intolerance and treating autoimmune2024
Small molecule inhibitors of ALDH and uses thereof2024
Compositions and methods for reducing immune intolerance and treating autoimmune2023
Glucosylceramide synthase inhibitors and therapeutic methods using the same2022
Inhibitors of Rho/MRTF/SRF-mediated gene transcription and methods for use of th2020
Inhibitors of myocardin-related transcription factor and serum response factor (2020
Deuterated amlexanox2020
G protein-coupled receptor kinase inhibitors and methods for use of the same2019
Glucosylceramide synthase inhibitors and therapeutic methods using the same2019
G protein-coupled receptor kinase 2 inhibitors and methods for use of the same2018
Deuterated amlexanox2018